Endocrinology & Metabolic Syndrome
Open Access
ISSN: 2161-1017
ISSN: 2161-1017
Dr. Michael Rodriguez
Stanford University, USA
Scientific Tracks Abstracts: Endocrinol Metab Syndr
Managing type 1 diabetes (T1D) requires continuous blood glucose monitoring and insulin administration. Artificial pancreas systems aim to automate this process but face challenges in accuracy and user compliance. A randomized controlled trial evaluated a novel artificial pancreas algorithm in 200 patients over six months. Outcomes included glucose variability, time-in-range metrics, and user satisfaction. The new system demonstrated superior glucose control with a 25% reduction in variability compared to standard therapy. User feedback highlighted improved quality of life and reduced mental burden. Enhanced algorithms can revolutionize T1D management, paving the way for broader adoption of artificial pancreas systems.
Dr. Michael Rodriguez specializes in endocrinology and diabetes technology. He is a leading researcher in artificial pancreas systems and has contributed to developing algorithms that enhance glucose monitoring accuracy. His work bridges the gap between cutting-edge technology and practical diabetes management solutions.